🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The LONG-LIFE study is a randomized Phase I, dose-ranging trial designed to...
Status
Not Yet Recruiting
Location
Vail Health Behavioral Health
Start Date
2026-12
Trial ID
NCT07719088
Treatments Being Tested
The purpose of this study is to determine the safety and feasibility of per...
Status
Recruiting
Location
Ghent University Hospital
Start Date
2024-05-21
Trial ID
NCT06378229
Treatments Being Tested
This study aims to investigate the effects of oral psilocybin on OCD sympto...
Status
Completed
Location
Connecticut Mental Health Center
Start Date
2018-11-13
Trial ID
NCT03356483
Treatments Being Tested
The Safety and Tolerability of COMP360 in Participants with Post-traumatic ...
Status
Completed
Location
Sunstone Therapies
Start Date
2022-06-10
Trial ID
NCT05312151
Treatments Being Tested
The study is a randomized, double-blind, placebo-controlled, expectancy-con...
Status
Not Yet Recruiting
Location
Connecticut Mental Health Center
Start Date
2026-08-31
Trial ID
NCT07693153
Treatments Being Tested
MLS101 is being developed as a low dose psilocybin, that can be administere...
Status
Completed
Location
CMAX Clinical Research
Start Date
2024-11-08
Trial ID
NCT06643637
Treatments Being Tested
Psilocybin is a classic serotonergic hallucinogen acting on the 5-HT2A rece...
Status
Completed
Location
University Hospital Basel, Clinical Trial Unit
Start Date
2019-07-04
Trial ID
NCT03912974
Treatments Being Tested
The PEARL Pilot is a phase II open-label trial. Participants will receive a...
Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2024-06-06
Trial ID
NCT06416085
Treatments Being Tested
This trial aims to examine the safety and efficacy of small (2mg) sub-hallu...
Status
Completed
Location
Psych Research
Start Date
2023-07-15
Trial ID
NCT05259943
Treatments Being Tested
The purpose of this study is to see if psilocybin, an investigational drug,...
Status
Completed
Location
Canadian Rapid Treatment Centre of Excellence (CRTCE)
Start Date
2021-11-19
Trial ID
NCT05029466
Treatments Being Tested